UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals

PLoS pathogens, 2010-08, Vol.6 (8), p.e1001028-e1001028

2010

Link zum Volltext

Verfügbarkeit prüfen

An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1

Frontiers in plant science, 2023-08, Vol.14, p.1233666-1233666

2023

Link zum Volltext

Verfügbarkeit prüfen

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis

PLoS pathogens, 2017-12, Vol.13 (12), p.e1006793-e1006793

2017

Link zum Volltext

Verfügbarkeit prüfen

The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells

PLoS pathogens, 2013-11, Vol.9 (11), p.e1003776-e1003776

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules

Current topics in medicinal chemistry, 2011-12, Vol.11 (24), p.2997

2011

Link zum Volltext

Verfügbarkeit prüfen

A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens

PloS one, 2015-05, Vol.10 (5), p.e0125581-e0125581

2015

Link zum Volltext

Verfügbarkeit prüfen

Recent Insights into the HIV/AIDS Pandemic

Microbial cell, 2016-09, Vol.3 (9), p.451-474

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans

EBioMedicine, 2015-10, Vol.2 (10), p.1464-1477

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study

PloS one, 2014-01, Vol.9 (1), p.e85371-e85371

2014

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 infection of endothelial cells, dependent on flow-induced ACE2 expression, drives hypercytokinemia in a vascularized microphysiological system

Frontiers in cardiovascular medicine, 2024, Vol.11, p.1360364-1360364

2024

Link zum Volltext

Verfügbarkeit prüfen

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

PloS one, 2016-08, Vol.11 (8), p.e0160341-e0160341

2016

Link zum Volltext

Verfügbarkeit prüfen

A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1

PloS one, 2013-08, Vol.8 (8), p.e72054-e72054

2013

Link zum Volltext

Verfügbarkeit prüfen

4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms

PloS one, 2010-03, Vol.5 (3), p.e9786

2010

Link zum Volltext

Verfügbarkeit prüfen

High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris

Journal of biotechnology, 2007-03, Vol.128 (4), p.735-746

2007

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells

Cellular immunology, 2023-04, Vol.386, p.104691-104691, Article 104691

2023

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope

Journal of molecular biology, 2011-12, Vol.414 (3), p.460-476

2011

Link zum Volltext

Verfügbarkeit prüfen

Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM

Biochimica et biophysica acta, 2015-10, Vol.1854 (10), p.1536-1544

2015

Link zum Volltext

Verfügbarkeit prüfen

Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5

Molecular immunology, 2008-02, Vol.45 (4), p.1027-1034

2008

Link zum Volltext

Verfügbarkeit prüfen

A welcome burst of human antibodies

Nature biotechnology, 2008-08, Vol.26 (8), p.886-887

2008

Link zum Volltext

Verfügbarkeit prüfen

Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?

AIDS research and human retroviruses, 2007-11, Vol.23 (11), p.1405

2007

Link zum Volltext

Verfügbarkeit prüfen

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals: e1001028

PLoS pathogens, 2010-08, Vol.6 (8)

2010

Link zum Volltext

Verfügbarkeit prüfen

A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1: e72054

PloS one, 2013-08, Vol.8 (8)

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals

An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis

The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells

Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules

A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens

Recent Insights into the HIV/AIDS Pandemic

HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study

SARS-CoV-2 infection of endothelial cells, dependent on flow-induced ACE2 expression, drives hypercytokinemia in a vascularized microphysiological system

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1

4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms

High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition

Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells

Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope

Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM

Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5

A welcome burst of human antibodies

Correction: The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells

Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals: e1001028

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14 + monocytes is associated with a decreased risk of SIV mac251 acquisition

A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1: e72054

Aktive Filter

Suchergebnisse filtern